Prithviraj Bose, M.D. M.D. Anderson Cancer Center, Department
Form 483 issued April 30, 2026 · Houston, Texas
- Inspection
- Apr 27 – Apr 30, 2026
- Investigator
- Terri E. Gibson
- Observations
- 1
- Pages
- 3
- FEI number
- 3043129636
In short: On April 30, 2026, FDA issued a Form 483 with 1 observation to Prithviraj Bose, M.D. M.D. Anderson Cancer Center, Department in Houston, Texas (FEI 3043129636) after an inspection that ran Apr 27 – Apr 30, 2026. The investigator was Terri E. Gibson. Most observations concern clinical (BIMO); the most-cited regulation is 21 CFR 312.60 (general responsibilities of investigators).
At a glance
1 of 1 observations on this 483 concern clinical (bimo).
Most cited: 21 CFR 312.60 (1×)
What FDA observed
Preview: the opening words of each observation- 01
An investigation was not conducted in accordance with the signed statement of…
This inspection in context
Terri E. Gibson
1 document · 2026
Cites 312.60 (general responsibilities of investigators) more than any other section. Most of their documents are for sites in Texas.
The firmPrithviraj Bose, M.D. M.D. Anderson Cancer Center, Department history
The site's inspection history, in date order.
Similar 483sOther sites cited under 312.60
See how FDA wrote the same problem up elsewhere.
Questions about this 483
What did FDA find at Prithviraj Bose, M.D. M.D. Anderson Cancer Center, Department?
FDA listed 1 observation on this Form 483, mostly about clinical (BIMO). The most-cited regulation is 21 CFR 312.60 (general responsibilities of investigators). The opening words of each observation are shown on this page.
Who inspected Prithviraj Bose, M.D. M.D. Anderson Cancer Center, Department?
Terri E. Gibson is named on this Form 483, for the inspection of Apr 27 – Apr 30, 2026. Each investigator has a profile showing what they cite most.
When was Prithviraj Bose, M.D. M.D. Anderson Cancer Center, Department inspected by FDA?
The inspection ran Apr 27 – Apr 30, 2026, and the Form 483 is dated April 30, 2026.
How do I get the full Form 483 for Prithviraj Bose, M.D. M.D. Anderson Cancer Center, Department?
Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.